Polyurethane Foam on the Heel for Prevention in Children

Overview

The post-operative treatment of pediatric patients operated for the correction of flat foot, sees today the use of preformed leg-foot splint (Walker) as an alternative to the application of plaster casts. The change of the immobilization system has led to the appearance of problems of tolerability in particular in the skin. The aim of the study is to assess whether by placing a polyurethane foam dress at the heel in the immediate postoperative period until removal of the Walker, the rate of skin lesion and pain is reduced.

Full Title of Study: “Effectiveness of Polyurethane Foam in Preventing the Onset of Pressure Sores in a Pediatric Orthopedic Population: Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 31, 2015

Interventions

  • Device: polyurethane foam dress
    • Application of the polyurethane foam dress at the heel in the immediate postoperative period before applied the Walker

Arms, Groups and Cohorts

  • Experimental: Polyurethane foam
  • No Intervention: standard care
    • Only application of the Walker in the immediate postoperative period.

Clinical Trial Outcome Measures

Primary Measures

  • Heel Pressure Sores (Numbers of Participants With Heel Pressure Sores)
    • Time Frame: every day until discharge (expected average of 3 days)
    • Numbers of Participants With Heel Pressure Sores of all grade Detected According to the Classification of the Scale of the National Pressure Ulcer Advisory Panel -N.P.U.A.P.: Grade 1: Non-blanchable erythema of intact skin. Discoloration of the skin, warmth, oedema, induration or hardness may also be used as indicators, particularly in individuals with darker skin. Grade 2: Partial thickness skin loss involving epidermis, dermis, or both. The ulcer is superficial and presents clinically as an abrasion or blister. Grade 3: Full thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia. Grade 4: Extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures with or without full thickness skin loss.

Secondary Measures

  • Pain (Score on the “Numeric Rating Scale”)
    • Time Frame: up to the first 3 days post intervention
    • Pain Score on the “Numeric Rating Scale” > 3. The scale had values from 0 to 10 where zero represented no pain and 10 the worst possible pain. More than 3 means pain.

Participating in This Clinical Trial

Inclusion Criteria

  • Children aged > 3 years underwent surgery for flat foot – Children with intact skin at the heel Exclusion Criteria:

  • Caregivers who cannot speak Italian – Those who refuse to give their consent to take part in the study – Patients with lower limb casts after surgery

Gender Eligibility: All

Minimum Age: 3 Years

Maximum Age: 18 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Istituto Ortopedico Rizzoli
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Caterina Guerra, RN, Principal Investigator, Istituto Ortopedico Rizzoli

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.